As you know, Parkinson’s is a degenerative neurological condition with unknown etiology and with no known cure, although exposure to environmental toxins is a suspected contributing factor or alternatively an outright cause. Elevating NAD+ tissue levels, such as with our Pricera formulation have been shown as indicated in the following study to provide potential tremendous benefit to those dealing with Parkinson’s. From the website NADH.com: In an open label trial with 885 Parkinsion’s disease patients  the following results were achieved by optimizing NAD+ level in study conducted in Austria by J.G.D. Birkmeyer, MD and colleagues: As one would expect, the earlier in the progression of the patient’s Parkinson’s the better the chance of a successful outcome. The clinical trial showed 78% of the patients taking NADH experienced varying levels of beneficial improvement. The percentages in improvement were:
  • 19.3% of the patients showed a very good (30% to 50%) improvement
  • 58.8% of the patients showed a moderate (10 – 30 %) improvement.
  • 21.8 % of the patients did not respond to the NADH
Parkinson’s Disease and NADH Treatments Summary: Good news, 78% of the patients in a Parkinson’s disease clinical study experienced positive improvements when taking an NADH supplement. NADH is a nutritional supplement that is a natural, energy-giving, co-enzyme found within every human cell. Since the mid-eighties, NADH has been used in Europe to successfully treat more than 3,000 Parkinsons patients. To validate these treatments, an open label clinical trial study was held with 885 Parkinson’s disease patients taking a daily 25mg NADH supplement (for the actual study, see the link below). The clinical study findings validated that in 78% of the cases, patients taking NADH reported positive improvements in their condition. The Clinical Testing: These treatments were in Europe, and not in the US. A majority of the Parkinson’s disease patients experienced varying levels of positive improvements in their condition. To validate these results, an open label trial with 885 Parkinsion’s disease patients were given 25mg of NADH daily. About half of the patients received NADH by intravenous means and the other half received oral tablets. The patients that received the 25mg of NADH oral tablets experienced the best results. (The actual Parkinson’s disease clinical study is available, see the link below.) The study found there were three things that had significant influence on the improvement in condition. They are:
  • the degree of the patient’s disability before the treatment
  • the duration of the disease within the patient before the treatment
  • the age of the patient
In the simplest of terms, the younger patients, with a shorter duration of the disease have a better chance to obtain the most significant improvements in Parkinson’s disease symptoms. The stages of the disease are important. If the Parkinson’s disease is in the most advanced stages, it is very difficult to show improvement. The clinical tests showed 78% of the patients taking NADH experienced varying levels of beneficial improvement. The percentages in improvement were:
  • 19.3% of the patients showed a very good (30% to 50%) improvement
  • 58.8% of the patients showed a moderate (10 – 30 %) improvement.
  • 21.8 % of the patients did not respond to the NADH
The most important things to remember about the NADH, is that NADH is found in every human cell, and:
  • NADH increases the levels of cellular energy (ATP). The more NADH cells have — the more ATP-energy cells produce. NADH increases cell longevity.
  • NADH is a powerful antioxidant, a scavenger of free radicals. According to Dr. Passwater, “NADH may just be the most powerful antioxidant”
  • NADH is the active ingredient in cellular repair and DNA repair.  It repairs cellular damage.
  • NADH stimulates the immune system.
  • NADH enhances the production of dopamine, a very important brain chemical (also known as a neurotransmitter)
  • NADH increases the bio-availability of nitric oxide, known to provide increased blood flow, oxygen delivery, glucose uptake, muscle velocity, power output, and muscle growth
Here is a testimonial from a client of mine who has achieved some remarkable improvement from her daily consumption of Pricera. The most significant improvement was in her energy levels. For a number of years I have been dealing with low energy and stamina, Chronic Fatigue and hand tremors. One of the key areas where Pricera impacts me is my energy levels – in the past, I often could only work for 4-5 hours before I felt exhausted and would have to stop. Some days it felt like my energy levels were so depleted that it was a struggle to get out of bed. Since starting on the Pricera, I have experienced a tremendous boost to my energy levels and I can now work 8-10 hours at a stretch. I have gained more stamina, energy and clarity and I have seen a significant improvement in my exercise capacity. For myself, Pricera has been a life saver, and I will not miss a single day taking it! MG Vancouver, BC If you are not targeting the optimization of NAD+ levels in your patients it is my opinion – based upon the published research that you are not addressing one of the key causes of the development of age related chronic, degenerative diseases. Reach out to me if you have some questions or you would like to get in some Pricera for yourself and your patients. Here is a link to Birkmeyer’s published paper on the benefits for Parkinson’s conditions which can be achieved by optimizing NAD+ levels. Copyright © 2020 Robert Lamberton, All rights reserved